WORLD PEPTIDEFOUNDATION
← Master Registry

Published peptide research references

Tabimorelin

Governed registry record

2 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.

Approved source records

  1. A clinical study investigating the pharmacokinetic interaction between NN703 (tabimorelin), a potential inhibitor of CYP3A4 activity, and midazolam, a CYP3A4 substrate.

    DOI: 10.1007/s00228-002-0539-1

    Source identity and connection checked by Codex (AI).

  2. The pharmacokinetics, pharmacodynamics, safety and tolerability following 7 days daily oral treatment with NN703 in healthy male subjects.

    DOI: 10.1054/ghir.2000.0188PMID: 11437473

    Source identity and connection checked by Codex (AI).

Legacy research context

Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.

Researchers represented

  • Lange T
  • Thomas A
  • Görgens C
  • Bidlingmaier M
  • Schilbach K
  • Fichant E
  • Delahaut P
  • Thevis M
  • Zdravkovic M
  • Olsen AK
  • Christiansen T
  • Schulz R
  • Taub ME
  • Thomsen MS
  • Rasmussen MH
  • Ilondo MM
  • Holm AM
  • Johansen PB
  • Ahnfelt-Rønne I
  • Rømer J
  • Eliot L
  • Agersoe H
  • Falch JF
  • Søgaard B
  • Ynddal L